Humanigen, Inc. (HGEN) is a clinical-stage biopharmaceutical company seeking to transform the treatment of cancers and infectious diseases, including COVID-19, by preventing and treating cytokine storm via its novel, cutting-edge anti-human granulocyte macrophage-colony stimulating factor (GM-CSF) monoclonal antibody neutralization and gene-knockout platforms. Its proprietary Humaneered® monoclonal antibodies, designed to optimize antibody properties, show promise in prevention/treatment of cytokine storm induced by SARS-CoV-2 (COVID-19), chimeric antigen receptor T-cell (CAR-T) therapy and graft versus host disease (GvHD) by neutralizing GM-CSF which is up-regulated in these conditions.
Looking for a particular Humanigen, Inc. employee's phone or email?
Humanigen, Inc. Questions
The Humanigen, Inc. annual revenue was $324000 in 2026.
Omar Ahmed is the Senior Vice President of Humanigen, Inc..
1 people are employed at Humanigen, Inc..
Humanigen, Inc. is based in Short Hills, New Jersey.
The NAICS codes for Humanigen, Inc. are [32541, 325, 32, 3254].
The SIC codes for Humanigen, Inc. are [28, 283].
Top Humanigen, Inc. Employees
-
Omar Ahmed
Senior Vice President at Humanigen, Inc.
New York, NY, US
Related Companies
